1. Repositorio Institucional UCA
  2. Research Outputs

Browsing by Subject ENFERMEDADES NEURODEGENERATIVAS


???browse.nav.jump.subject???
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 25  next >
PreviewIssue DateTitleAuthor(s)
preliminary-study-low.pdf.jpg2021A preliminary study of low-dose angiotensin 1-7 plus the pineal hormone melatonin in the treatment of human systemic diseases other than cancer and autoimmune pathologiesLissoni, Paolo ; Porta, Enrica ; Rovelli, Franco ; Messina, Giusy ; Lissoni, Arianna ; Porro, Giorgio ; Porro, Davide ; Di Fede, Giuseppe ; Monzon, Alejandra ; Sassola, Andrea ; Cardinali, Daniel Pedro 
alterations-electrochemical-skin.pdf.jpg2022Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophyGeorges, Claire ; Pérez Lloret, Santiago ; Ory Magne, Fabienne ; Fabbri, Margherita ; Foubert Samier, Alexandra ; Meissner, Wassilios G. ; Rascol, Olivier ; Pavy-Le Traon, Anne 
contribution-trpc-channels-neuronal.pdf.jpg2021Contribution of TRPC channels in neuronal excitotoxicity associated with neurodegenerative disease and ischemic strokeJeon, Jaepyo ; Bu, Fan ; Sun, Guanghua ; Tian, Jin-Bin ; Ting, Shun-Ming ; Li, Jun ; Aronowski, Jaroslaw ; Birnbaumer, Lutz ; Freichel, Marc ; Zhu, Michael X. 
effects-angiotensin-1-type-receptor.pdf.jpg2021Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI databaseUdovin, Lucas Daniel ; Otero Losada, Matilde ; Bordet, Sofía ; Chevalier, Guenson ; Quarracino, Cecilia ; Capani, Francisco ; Pérez Lloret, Santiago 
environmental-enrichment-murine.pdf.jpg2023Environmental enrichment in murine models and its translation to human factors improving conditions in alzheimer diseaseColavitta, María Florencia ; Grasso, Lina ; Barrantes, Francisco José 
fluoxetine-symptomatic-treatment-atrophy (1).pdf.jpg2021Fluoxetine for the symptomatic treatment of Multiple System Atrophy : the MSA-FLUO trialRascol, Olivier ; Cochen De Cock, Valérie ; Pavy-Le Traon, Anne ; Foubert Samier, Alexandra ; Thalamas, Claire ; Sommet, Agnès ; Rousseau, Vanessa ; Pérez Lloret, Santiago ; Fabbri, Margherita ; Azulay, Jean Philippe ; Corvol, Jean-Christophe ; Couratier, Philippe ; Damier, Philippe ; Defebvre, Luc ; Durif, Franck ; Geny, Christian ; Houeto, Jean-Luc ; Remy, Philippe ; Tranchant, Christine ; Verin, Marc ; Tison, François ; Meissner, Wassilios G. 
genetics-neurogenic-orthostatic.pdf.jpg2023Genetics of neurogenic orthostatic hypotension in Parkinson’s disease, results from a cross-sectional in silico studyChevalier, Guenson ; Udovin, Lucas D. ; Otero Losada, Matilde ; Bordet, Sofía ; Capani, Francisco ; Luo, Sheng ; Goetz, Christopher ; Pérez Lloret, Santiago 
heart-rate-variability-mild.pdf.jpg2020Heart rate variability and mild cognitive impairment in parkinson’s diseaseMerello, Marcelo ; Vigo, Daniel Eduardo ; Abulafia, Carolina Andrea ; Terroba-Chambi, Cinthia 
immunomodulation-induced-central.pdf.jpg2021Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disordersPalumbo, María Laura ; Moroni, Alejandro David ; Quiroga, Sofia ; Castro, María Micaela ; Burgueño, Adriana Laura ; Genaro, Ana María 
melatonin-chronobiotic-cytoprotective-agent.pdf.jpg2021Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s diseasePérez Lloret, Santiago ; Cardinali, Daniel Pedro 
miedo-caidas-enfermedades.pdf.jpg2021Miedo a las caídas en las enfermedades neurodegenerativas de los ganglios basales : rol de la disfunción cognitiva, conductual y autonómica en la asociación entre la percepción de riesgo y el miedo a las caídasTerroba-Chambi, Cinthia 
neuroprotection.pdf.jpg2018Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndromeHerrera, María Inés ; Udovin, Lucas Daniel ; Toro-Urrego, Nicolás ; Kusnier, Carlos Federico ; Luaces, Juan P. ; Otero Losada, Matilde ; Capani, Francisco 
neuroprotective-properties-cannabinoids.pdf.jpg2020Neuroprotective properties of cannabinoids in cellular and animal models : hypotheses and factsUdovin, Lucas Daniel ; Aguilar, Andrea ; Kobiec, Tamara ; Herrera, María Inés ; Pérez Lloret, Santiago ; Toro-Urrego, Nicolás ; Kölliker Frers, Rodolfo 
on-diagnosis-pain-parkinson.pdf.jpg2022On the diagnosis of pain in Parkinson disease : a mechanism-based approachMylius, Veit ; Pérez Lloret, Santiago ; Ciampi de Andrade, Daniel 
parenting-sstyles-coping-strategies-pku.pdf.jpg2021Parenting syles and coping strategies in PKU early detected childrenPardo Campos, María L. ; Enacan, Rosa ; Valle, Maria G. ; Chiesa, Ana 
parkinson-disease-era-novel.pdf.jpg2020Parkinson’s disease in the era of a novel respiratory virus pandemicOtero Losada, Matilde ; Kobiec, Tamara ; Udovin, Lucas Daniel ; Chevalier, Guenson ; Quarracino, Cecilia ; Menéndez Maissonave, Camila Belén ; Bordet, Sofía ; Capani, Francisco ; Pérez Lloret, Santiago 
relación-entre-perfiles-neurocognitivo.pdf.jpg2021Relación entre los perfiles neurocognitivo y motor en adultos mayores con enfermedad de parkinson inicialColavitta, María Florencia 
synergy-pandemics-social-isolatio.pdf.jpg2021Subramanian, I., Farahnik, J., y Mischley, L. (2020). Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life. Nature, 6 (28), 1-8, https://doi.org/10.1038/s41531-020-00128-9Colavitta, María Florencia 
cover.jpg.jpg2019Sueño lento como neuroprotector en el envejecimientoCardinali, Daniel Pedro 
genetics-basis-probable.pdf.jpg2023The genetic basis of probable rem sleep behavior disorder in Parkinson’s diseasePérez Lloret, Santiago ; Chevalier, Guenson ; Bordet, Sofía ; Barbar, Hanny ; Capani, Francisco ; Udovin, Lucas D. ; Otero Losada, Matilde 
Showing results 1 to 20 of 25  next >